October - December 2025 | Hematology, Transfusion and Cell Therapy

Advanced Search

Share

English Português

Home October - December 2025

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

portada-S2531137925X00079

Vol. 47. Issue 4.

(October - December 2025)

Original articles

Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation

Moazzam Shahzad, Muhammad Kashif Amin, Maggie Nelson, Abhinav Vyas, Joe S. Al-Ramahi, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, ... Muhammad Umair Mushtaq

Hematol Transfus Cell Ther. 2025;47:103961

Full text access

Share

Post-thaw dimethyl sulfoxide reduction in autologous peripheral blood progenitor cell suspensions

Miroslava Jandová, Pavel Měřička, Jiří Gregor, Miriam Lánská, Aleš Bezrouk, Dana Čížková, Jakub Radocha

Hematol Transfus Cell Ther. 2025;47:103965

Full text access

Share

Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process

Ludmila Peres Gargano, Mariana Millan Fachi, Layssa Andrade Oliveira, Clarisse Lobo, Katharina Nelly Tobos Melnikoff, Selma Soriano, Marta da Cunha Lobo Souto Maior, Meline Rossetto Kron-Rodrigues, ... Rosa Camila Lucchetta

Hematol Transfus Cell Ther. 2025;47:103964

Full text access

Share

Overall survival in multiple myeloma in Brazil: A cohort of 16 years

Deborah Marta do Santos Oliveira, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, Isabella Zuppo Laper, Pâmela Santos Azevedo, Adriano de Paula Sabino, Marisa Yurico Itonaga, Carmino Antonio de Souza, ... Augusto Afonso Guerra Junior

Hematol Transfus Cell Ther. 2025;47:103962

Full text access

Share

Risk factors associated with the use of red blood cells in elective cardiac surgeries: A patient blood management (PBM) view

Tainá Miotto de Souza, Cláudio Lucas Miranda, Andrezza Belluomini Castro, Patrícia Carvalho Garcia-Bonichini

Hematol Transfus Cell Ther. 2025;47:103987

Full text access

Share

Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center study

Barbara Puga, Francisca Bass, Javiera Molina, Rafael Benavente, Alejandro Andrade, Alejandro Majlis, María Elena Cabrera, Mi Kwon

Hematol Transfus Cell Ther. 2025;47:103982

Full text access

Share

Experience with second allogeneic hematopoietic stem cell transplantation in Chilean patients: A single-center study

Yorman Flores, Javier Díaz, Patricio Rojas, José Salinas, Catherine Gutiérrez, Marcela Vidal, Verónica Jara, Elizabeth Rivera, ... Mauricio Sarmiento

Hematol Transfus Cell Ther. 2025;47:103980

Full text access

Share

Coagulation factor stability and sterility of thawed fresh frozen plasma stored at 2-6 o C for five days: Towards optimizing utilization

Ruchika Bhartia, Paramjit Kaur, Kshitija Mittal, Anita Tahlan, Varsha Gupta, Ravneet Kaur, Gagandeep Kaur

Hematol Transfus Cell Ther. 2025;47:103988

Full text access

Share

Correlation of serum interleukin-8 with disease severity in aplastic anemia

Shahla’a Fadhil Sabir, Huda Ibraheem Abd AL-Lateef, Naam Ali Hamza

Hematol Transfus Cell Ther. 2025;47:103989

Full text access

Share

Immunological consequences of past transfusions in kidney transplant candidates: A focus on anti-HLA antibody formation

Tamara Perić, Svetlana Vojvodić

Hematol Transfus Cell Ther. 2025;47:103990

Full text access

Share

Review articles

COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy

Yigit Baykara, Kaan Sevgi, Yamac Akgun

Hematol Transfus Cell Ther. 2025;47:103963

Full text access

Share

Case reports

An enigmatic tale of macrophages in bone marrow causing inflammation of the brain: A case report on CNS HLH

Ivy E. Verriet, Jessica Liu, Adrienne Fulford, Uday Deotare

Hematol Transfus Cell Ther. 2025;47:103981

Full text access

Share

Daratumumab-EPOCH for transformed anaplastic multiple myeloma

Espen Stormorken, Anders Erik Astrup Dahm

Hematol Transfus Cell Ther. 2025;47:103977

Full text access

Share

Letters to the editor

The battle against pediatric retinoblastoma: insights from 2024 medical literature

Yoshiyasu Takefuji

Hematol Transfus Cell Ther. 2025;47:103839

Full text access

Share

Electroacupuncture as a tool to stimulate bone marrow megakaryocytes in mice: A pilot study

Luiza P.R. dos Santos Mariani, Rita M.V.M. Rocha, Lidiane M.B. Leite, Alexandra C. Senegaglia, Pedro V. Michelotto

Hematol Transfus Cell Ther. 2025;47:103966

Full text access

Share

The tower of babel in hematology: The World Health Organization and International Consensus Classification systems

Daniel Mazza Matos, Eduardo Magalhaes Rego

Hematol Transfus Cell Ther. 2025;47:103985

Full text access

Share

Regarding “Challenges in diagnosing thrombotic thrombocytopenic purpura”

Cilomar Martins de Oliveira Filho, Brian J. Carney

Hematol Transfus Cell Ther. 2025;47:103986

Full text access

Share

Fulminant hepatitis secondary to nivolumab in a patient with Hodgkin’s Lymphoma after complete remission

Ana Júlia Negrelli dos Santos, Arthur Gomes Oliveira Braga, Talita Maira Bueno da Silveira

Hematol Transfus Cell Ther. 2025;47:103983

Full text access

Share

Special content

Special Content

Images in clinical hematology

Howell-Jolly-like inclusions in granulocytes of a liver transplant recipient

Verónica Roldán Galiacho, Sara Hormaza de Jauregui, Lourdes Elicegui Fernández

Hematol Transfus Cell Ther. 2025;47:103978

Full text access

Share

VEXAS syndrome: more than just vacuoles

Marco P. Barros Pinto

Hematol Transfus Cell Ther. 2025;47:103984

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics